SEK 36.6
(3.39%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 7.1 Billion SEK | 0.52% |
2022 | 7.06 Billion SEK | 9.58% |
2021 | 6.44 Billion SEK | 13.34% |
2020 | 5.69 Billion SEK | -3.97% |
2019 | 5.92 Billion SEK | 92.93% |
2018 | 3.07 Billion SEK | -3.09% |
2017 | 3.16 Billion SEK | -2.01% |
2016 | 3.23 Billion SEK | 17.81% |
2015 | 2.74 Billion SEK | 2.66% |
2014 | 2.67 Billion SEK | 99.11% |
2013 | 1.34 Billion SEK | 21.11% |
2012 | 1.1 Billion SEK | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q2 | 7.49 Billion SEK | 3.85% |
2024 Q3 | 7.26 Billion SEK | -3.11% |
2024 Q1 | 7.22 Billion SEK | -7.13% |
2023 Q2 | 7.44 Billion SEK | 3.65% |
2023 Q1 | 7.17 Billion SEK | 1.57% |
2023 Q4 | 7.77 Billion SEK | 13.49% |
2023 FY | 7.77 Billion SEK | 10.0% |
2023 Q3 | 6.85 Billion SEK | -7.93% |
2022 Q3 | 6.83 Billion SEK | -0.76% |
2022 FY | 7.06 Billion SEK | 9.58% |
2022 Q1 | 6.55 Billion SEK | 1.61% |
2022 Q2 | 6.88 Billion SEK | 5.1% |
2022 Q4 | 7.06 Billion SEK | 3.39% |
2021 FY | 6.44 Billion SEK | 13.34% |
2021 Q2 | 6.2 Billion SEK | 7.47% |
2021 Q3 | 6.36 Billion SEK | 2.66% |
2021 Q1 | 5.77 Billion SEK | 1.41% |
2021 Q4 | 6.44 Billion SEK | 1.3% |
2020 FY | 5.69 Billion SEK | -3.97% |
2020 Q2 | 6.02 Billion SEK | 0.85% |
2020 Q3 | 5.87 Billion SEK | -2.42% |
2020 Q4 | 5.69 Billion SEK | -3.18% |
2020 Q1 | 5.97 Billion SEK | 0.79% |
2019 Q3 | 5.87 Billion SEK | -1.84% |
2019 FY | 5.92 Billion SEK | 92.93% |
2019 Q4 | 5.92 Billion SEK | 0.9% |
2019 Q2 | 5.98 Billion SEK | 31.91% |
2019 Q1 | 4.53 Billion SEK | 47.67% |
2018 Q4 | 3.07 Billion SEK | 0.59% |
2018 FY | 3.07 Billion SEK | -3.09% |
2018 Q1 | 3.17 Billion SEK | 0.06% |
2018 Q2 | 3.15 Billion SEK | -0.66% |
2018 Q3 | 3.05 Billion SEK | -3.08% |
2017 Q1 | 3.2 Billion SEK | -0.77% |
2017 Q2 | 3.23 Billion SEK | 0.69% |
2017 Q4 | 3.16 Billion SEK | 0.48% |
2017 Q3 | 3.15 Billion SEK | -2.38% |
2017 FY | 3.16 Billion SEK | -2.01% |
2016 Q3 | 2.81 Billion SEK | -2.79% |
2016 Q2 | 2.89 Billion SEK | 15.82% |
2016 FY | 3.23 Billion SEK | 17.81% |
2016 Q4 | 3.23 Billion SEK | 14.76% |
2016 Q1 | 2.5 Billion SEK | -8.82% |
2015 FY | 2.74 Billion SEK | 2.66% |
2015 Q4 | 2.74 Billion SEK | 0.0% |
2015 Q1 | - SEK | 0.0% |
2014 FY | 2.67 Billion SEK | 99.11% |
2013 FY | 1.34 Billion SEK | 21.11% |
2012 FY | 1.1 Billion SEK | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Ambea AB (publ) | 12.97 Billion SEK | 45.24% |
Attendo AB (publ) | 17.53 Billion SEK | 59.475% |
ProstaLund AB (publ) | 10.21 Million SEK | -69437.98% |